Llamas Velasco, Sara Méndez Guerrero, Antonio Murcia García, Francisco José Ruiz Morales, Juan Manuel
Acute Pisa syndrome after administration of a single dose of mirtazapine [caso clínico] - Clinical neuropharmacology, 2013 - 36(4):133-4.
Formato Vancouver:
Méndez Guerrero A, Llamas S, Murcia FJ, Ruíz J. Acute Pisa syndrome after administration of a single dose of mirtazapine. Clin Neuropharmacol. 2013 Jul-Aug;36(4):133-4.
PMID: 23783006
Contiene 15 referencias
Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.
Acute Pisa syndrome after administration of a single dose of mirtazapine [caso clínico] - Clinical neuropharmacology, 2013 - 36(4):133-4.
Formato Vancouver:
Méndez Guerrero A, Llamas S, Murcia FJ, Ruíz J. Acute Pisa syndrome after administration of a single dose of mirtazapine. Clin Neuropharmacol. 2013 Jul-Aug;36(4):133-4.
PMID: 23783006
Contiene 15 referencias
Mirtazapine is an antidepressant with an adequate safety profile used in major depression. Adverse effects have been reported in the field of movement disorders, but none as truncal segmental dystonia (Pisa syndrome). We describe the case of a woman who developed Pisa syndrome after a single dose of mirtazapine.
